New Intarcia CMO Fred Fiedorek
Intarcia has a new CMO according to their completely redesigned website. Fred Fiedorek has seemingly replaced Michelle Baron, and this is a big deal. Fiedorak assumes the role of Chief Medical Officer and Global Head of Regulatory Affairs at Intarcia, where he leaves Rhythm Pharmaceuticals in Boston after working on relamorelin and setmelanotide.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.